OINDPnews


Proveris Scientific

Business

GSK launches Arnuity Ellipta and Incruse Ellipta in the US

GlaxoSmithKline has announced that both the Arnuity Ellipta fluticasone furoate DPI and the Incruse Ellipta umeclidinium bromide DPI are now available in the US. Arnuity Ellipta was approved by the FDA in August 2014 for the treatment of asthma. The FDA approved Incruse Ellipta for the treatment of COPD in April 2014. GSK Senior VP of the US Respiratory Business … [Read more...] about GSK launches Arnuity Ellipta and Incruse Ellipta in the US

Boehringer Ingelheim launches Spiriva Respimat in the US

Boehringer Ingelheim has announced that the Spiriva Respimat tiotropium soft mist inhaler is now available in the United States. Patients will also still be able to purchase Spiriva Handihaler, the company said. The FDA approved Spiriva Respimat for the treatment of COPD in September 2014. Boehringer Ingelheim Pharmaceuticals VP, Clinical Development & Medical … [Read more...] about Boehringer Ingelheim launches Spiriva Respimat in the US

NovaBiotics raises £5 million

NovaBiotics, which has plans to develop an inhaled version of its Lynovex cysteamine (NM001) for the treatment of cystic fibrosis, has announced that it has raised £5 million in a private placement from Woodford Investment Management. According to the company, "NM001 has a unique antibacterial-mucoactive-antibiofilm mode of action that kills bacteria, disables … [Read more...] about NovaBiotics raises £5 million

Aradigm gets European and Australian patents for Pulmaquin

Aradigm Corporation announced that it has received patents for its Pulmaquin inhaled ciprofloxacin from the European and Australian patent offices. The European patent (EU Patent No. 2,079,443) is titled “Dual Action, Inhaled Formulations Providing Both an Immediate and Sustained Release Profile”; the Australian patent (AU2012211514) is titled “Concentrated, … [Read more...] about Aradigm gets European and Australian patents for Pulmaquin

Alfred Mann steps down as CEO of MannKind Corporation, company gets milestone payment for Afrezza

According to MannKind Corporation, Hakan Edstrom has taken over as CEO after company founder Alfred Mann stepped down from that position effective January 9, 2015. Mann will become the Executive Chairman and "intends to remain engaged with the company in business matters, including those relating to development and financing of MannKind's future therapies," the … [Read more...] about Alfred Mann steps down as CEO of MannKind Corporation, company gets milestone payment for Afrezza

Verona Pharma appoints Chief Medical Officer, creates US subsidiary

Verona Pharma has announced that Kenneth Newman, a former Acton Pharmaceuticals CMO and former Boehringer Ingelheim VP, Medical Affairs, will become Verona's Chief Medical Officer as of January 1. At Acton, Newman headed up clinical development and regulatory activities for several OINDPs. Acton was acquired by Meda in 2013. The new position will be based in the … [Read more...] about Verona Pharma appoints Chief Medical Officer, creates US subsidiary